Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
10 mars 2025 07h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. FDA for the STARI clinical study.
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
20 févr. 2025 07h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
Foundation for Sarcoidosis Research (FSR) Announces $300,000 in Grant Funding to Improve Diagnosis and Treatment of Sarcoidosis
03 févr. 2025 11h30 HE
|
Foundation for Sarcoidosis Research
FSR increases funding to support sarcoidosis research
Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences
16 janv. 2025 18h43 HE
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research issues urgent public health alert in response to California wildfires, emphasizing heightened risk of sarcoidosis.
AerWave Completes First-in-Human Study to Advance Disease-Modifying Ultrasound-Based Therapy for COPD and Asthma
08 janv. 2025 08h00 HE
|
AerWave Medical, Inc.
AerWave Completes First-in-Human Study to Advance Disease-Modifying Ultrasound-Based Therapy for COPD and Asthma
35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity
26 nov. 2024 08h00 HE
|
35Pharma Inc.
35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity
Monaghan Medical Wins 2024 AARC Zenith Award
03 oct. 2024 04h00 HE
|
Monaghan Medical Corporation
Monaghan Medical Corporation has been honored with the prestigious 2024 Zenith Award from the American Association for Respiratory Care (AARC). This award
ECMO Program at Texas Health Dallas Helps Preschool Teacher Overcome Pulmonary Embolism
02 oct. 2024 10h18 HE
|
Texas Health Resources
Dallas, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Linda Potthoff woke up with severe breathing problems. She told her husband to call for medical help, just in case. That’s her last memory before...
Lungpacer Medical Announces PMA Submission for AeroPace® System
04 sept. 2024 09h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical today announced that its AeroPace System is under Food and Drug Administration (FDA) review in a premarket approval (PMA) application.
[Latest] Global Non-Small-Cell Lung Cancer Drug Market Size/Share Worth USD 68,888.6 Million by 2033 at a 8.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
21 mai 2024 03h30 HE
|
Custom Market Insights
Austin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type...